CD274 and nonpapillary renal cell carcinoma: Here we assessed for clinical characteristics that correlate with outcomes in a cohort of patients with ccRCC treated with anti-PD1/PD-L1 and The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma cohort (TCGA-ccRCC).